Intellia Therapeutics News, Intellia Therapeutics Quote, NTLA Quote

Intellia Therapeutics (NQ:NTLA) Delayed: 11.42 +0.08 (0.71%)

Prev. Close

$11.34

Today 6M 1Y 5Y

Open

$11.60

52 Wk High

$30.40

52 Wk Low

$11.86

Day High

$11.68

Day Low

$10.91

P/E

N/A

EPS

$0.00

Volume

8,233,438

Friends, Peers and Foes (?): CRSP, EDIT, ANVS, CRSPN, BEAM (more...)

ALERTS | RSS

Oct 13, 2026 07:30 AM Intellia Therapeutics names new chief medical officer
Oct 13, 2026 07:30 AM Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
Oct 6, 2026 04:05 PM Form 4 Intellia Therapeutics, For: Oct 02 Filed by: Dube Michael P
Oct 6, 2026 06:11 AM Barclays Starts Intellia Therapeutics (NTLA) at Underweight
Oct 5, 2026 04:46 PM Form 144 Intellia Therapeutics, Filed by: Clark Eliana
Oct 2, 2026 04:01 PM Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 9, 2026 07:29 AM H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Sep 9, 2026 04:26 AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens
Sep 8, 2026 08:10 AM FDA accepts Intellia's lonvo-z application with priority review status
Sep 8, 2026 04:25 AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens on HAE Opportunity

Entities mentioned with NTLA

View All Entities